Trials / Conditions / Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
4 registered clinical trials studyying Advanced Lung Non-Squamous Non-Small Cell Carcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic NCT05017025 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Recruiting | Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer NCT04181060 | National Cancer Institute (NCI) | Phase 3 |
| Completed | Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung C NCT04173507 | SWOG Cancer Research Network | Phase 2 |
| Completed | Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic N NCT02520778 | National Cancer Institute (NCI) | Phase 1 |